Femtosecond laser and microkeratome-assisted Descemet stripping endothelial keratoplasty: first clinical results by Rosa, AM et al.
Femtosecond laser and microkeratome-assisted
Descemet stripping endothelial keratoplasty:
ﬁrst clinical results
Andreia Martins Rosa,1,2,3 Maria Fátima Silva,4 Maria João Quadrado,1,2,3
Esmeralda Costa,1,3 Inês Marques,1 Joaquim Neto Murta1,2,3
1Ophthalmology Unit, Centro
Hospitalar e Universitário de
Coimbra, Coimbra, Portugal
2Centro Cirúrgico de Coimbra,
Coimbra, Portugal
3Faculty of Medicine, University
of Coimbra, Coimbra, Portugal
4Visual Neuroscience
Laboratory, IBILI, Faculty of
Medicine, University of
Coimbra, Coimbra, Portugal
Correspondence to
Professor Joaquim Neto Murta,
Ophthalmology Unit, Centro
Hospitalar e Universitário de
Coimbra, Praceta Mota Pinto,
Coimbra 3049, Portugal;
jmurta@netcabo.pt
Received 22 July 2012
Revised 7 February 2013
Accepted 23 February 2013
To cite: Rosa AM, Silva MF,
Quadrado MJ, et al. Br J
Ophthalmol Published
Online First: [please include
Day Month Year]
doi:10.1136/bjophthalmol-
2012-302378
ABSTRACT
Aim To perform Descemet stripping automated
endothelial keratoplasty (DSAEK) using a novel technique
to obtain very thin (<100 mm) posterior corneal disks.
Methods Twenty ﬁve DSAEK grafts were prepared with
two sequential cuts: the ﬁrst cut, of variable thickness,
was made with a femtosecond laser and the second
with a 300 mm microkeratome head. Spectacle corrected
visual acuity, endothelial cell density evaluation with
specular microscopy and anterior segment optical
coherence tomography to measure central and peripheral
graft thickness was performed preoperatively and
postoperatively at 1, 3 and 6 months.
Results There were no irregular cuts or perforations
during tissue preparation. Central graft thickness was
79.6 mm (SD±14.5; range 54–98) and 69.3 mm
(SD±14.2; range 49–96) at 3 and 6 months. Corrected
distance visual acuity improved from 0.91 logMAR
preoperatively to 0.11 logMAR at 6 months. Donor
endothelial cells averaged 2675 cells/mm2 preoperatively
and 1729 cells/mm2 at 6 months. There were no graft
detachments.
Conclusions This new technique consistently yielded
very thin grafts (<100 mm), excellent visual acuity results
and good endothelial cell counts. No donor tissue was
wasted.
INTRODUCTION
Descemet stripping automated endothelial kerato-
plasty (DSAEK) has become the standard procedure
for Fuchs dystrophy and other endothelial dysfunc-
tion disorders.1 DSAEK consists of stripping a
patient’s diseased endothelium and replacing it
with healthy endothelium, Descemet’s membrane
and a layer of stroma prepared from a donor
cornea with an automated microkeratome.2 3
One limitation of DSAEK is that some eyes do
not achieve good visual acuity despite a clear
cornea and minimal residual astigmatism. This may
be due to interface irregularity, the presence of
donor posterior stroma or a thick endothelial
graft.4–6 The inﬂuence of endothelial graft thick-
ness on visual acuity in DSAEK is controversial,
with some authors reporting better results with
thinner grafts and others ﬁnding no correlation.6–11
However, in studies where no correlation was
found, grafts were relatively thick (>160 mm).8–10
Indeed, in none of these studies was graft thickness
less than 100 mm. The procedure to obtain thin
grafts carries a higher risk of perforation. Our
group has previously reported a technique that
combines a femtosecond laser with a
microkeratome to create grafts of less than 100 mm
in eye bank eyes (Murta et al, 2nd Eucornea
Congress, 2011).
We present below the ﬁrst clinical outcomes of
DSAEK performed with this new approach.
MATERIALS AND METHODS
Patients
This prospective study comprised 25 eyes from 25
patients with Fuchs endothelial dystrophy (14 eyes)
or pseudophakic bullous keratopathy (11 eyes).
Exclusion criteria were coexisting non-corneal
abnormalities, such as macular degeneration and
advanced glaucoma, and history of previous
corneal surgery or visually signiﬁcant corneal scar-
ring. There were no relevant coexisting systemic
diseases. Institutional review board approval was
obtained and patients were provided with informed
consent after the possible consequences of partici-
pation had been explained.
Surgical technique
Donor corneas were obtained from Fondazione
Banca Degli Occhi (Venice, Italy) preserved in
organ culture medium at 31°C. Each cornea was
mounted on an artiﬁcial anterior chamber (ALTK,
Moria SA, Antony, France) ﬁlled with balanced salt
solution (BSS, Alcon, Fort Worth, Texas, USA).
Central pachymetry was performed with an ultra-
sonic pachymeter (CorneoGage Plus 50 MHz;
Sonogage, Cleveland, Ohio, USA) after removal of
the epithelium. Five readings were averaged. The
BSS bottle was elevated to 220 cm and the tubing
clamped at 60 cm from the anterior chamber. Two
cuts were made. An Intralase FS60 femtosecond
laser (Abbott Medical Optics, Santa Ana,
California, USA) was used for the ﬁrst cut and a
Moria CBm microkeratome with a 300 mm cutting
head was used for the second. The thickness of the
ﬁrst cut was calculated as follows:
Femtosecond cut thickness
¼ Corneal pachymetry 410mm
*This ﬁgure is the sum of the theoretical microkera-
tome cut thickness (300 mm) plus the desired ﬁnal
graft thickness (110 mm).
Femtosecond settings were full lamellar cut,
diameter 9.5 mm, raster energy 1.5 mJ and anterior
side cut at 90°. No suction ring was used and
docking was straightforward. The ﬁrst anterior
stromal lenticule was easily removed following the
femtosecond cut. In no case was manual dissection
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needed. The second cut was performed immediately afterwards
with the 300 mm microkeratome head, keeping the manual rota-
tion speed constant and with total duration of approximately
5 s. The tubing was unclamped from the BSS bottle at 150 cm.
Donor tissue was removed by gently pulling the scleral rim
from the top of the anterior chamber and was transferred to an
8.5 mm Hessburg-Barron trephine (Katena Products, Denville,
New Jersey, USA).
Recipient preparation and donor insertion were performed as
previously described.12 In brief, the procedure consisted of strip-
ping Descemet’s membrane, performing an inferior iridectomy
to prevent pupillary block, transferring the graft using a Busin
glide (Moria SA) and ﬁlling the anterior chamber almost com-
pletely with air underneath the graft.
Seventeen patients were pseudophakic preoperatively.
Concurrent cataract surgery was performed in eight cases,
before the Descemet stripping. Surgeries were performed by
one surgeon ( JNM). Postoperative medication consisted of
oﬂoxacin 3 mg/ml and dexamethasone 1 mg/ml six times a day
for 2 weeks and then tapered according to clinical response.
Outcome analysis
Graft thickness was measured at 1, 3 and 6 months using anter-
ior segment optical coherence tomography (Spectralis Anterior
Segment Module, Heidelberg, Germany). The scanning line was
positioned on the 180° axis into the corneal vertex and mea-
surements were taken at the vertex and at 3 mm on either side
to obtain peripheral thickness (ﬁgure 1).
Corrected distance visual acuity (CDVA) with subjective
refraction was recorded preoperatively and at 1, 3 and 6 months
after surgery. Baseline donor endothelial cell density (ECD) was
provided by the eye bank and was measured postoperatively
with specular microscopy (Tomey EM-3000, Nagoya, Japan).
Statistical analysis was performed with IBM SPSS Statistics
V.19 (SPSS Inc, Chicago, USA). Repeated measures analysis of
variance with Bonferroni correction for multiple comparisons
was used after verifying that data did not signiﬁcantly deviate
from normal distribution (Kolmogorov–Smirnov test). All
results with p<0.05 were considered statistically signiﬁcant.
RESULTS
A total of 25 patients (17 female and 8 male subjects) aged
between 48 and 88 years (mean age 65.0±13.4 years) were
included. Average postoperative follow-up was 6 months (range
5–7 months). Tissue was prepared without perforations, irregu-
lar cuts or buttonholes.
Central preoperative donor corneal thickness after epithelium
removal was 542.4 mm (range: 505–600 mm). Central graft
thickness decreased continuously from 83.1 mm at the ﬁrst
month to 79.6 and 69.3 mm at 3 and 6 months (table 1 and
ﬁgure 2).
Multiple comparisons showed statistically signiﬁcant differ-
ences between the ﬁrst and sixth month central graft thickness
and between the third and sixth month central graft thickness
(F(2,44)=21.39; p<0.001; ηp
2=0.493, p<0.001 in both compari-
sons). The same analysis was performed for peripheral DSAEK
graft thickness but the differences were not signiﬁcant
(F(2,44)=0.189; p=0.828; ηp
2=0.009).
The linear Pearson correlation coefﬁcient was used to evaluate
the relationship between the obtained graft thickness and the
original donor corneal thickness. No statistically signiﬁcant cor-
relation was found at any time point (1 month: rPearson=−0.39,
p=0.33; 3 months: rPearson=−0.54, p=0.17 and for 6 months:
rPearson=−0.69, p=0.13).
CDVA continuously improved from 0.91 logMAR preopera-
tively to 0.15 and 0.11 logMAR at 3 and 6 months post-
operative (table 2 and ﬁgure 2). Statistically signiﬁcant
differences were found for CDVA between preoperative and at
3 and 6 months (F(2,42)=11.41; p=0.015; ηp
2=0.65; p=0.017
and p=0.013, respectively, multiple comparisons). No differ-
ences in CDVA were found between 3 and 6 months postopera-
tively (p=0.56). At 3 and 6 months, 60.0% and 85.7% of eyes
achieved CDVA of 20/30 or more. CDVA was 20/20 in 10% of
eyes at 3 months and 14.3% at 6 months. Spherical equivalent
increased from −1.31D preoperatively to −0.7D at 6 months.
Average precut ECD was 2675 cells/mm2 (SD±251) and
1729 cells/mm2 (SD±296) at 6 months, representing a 35.4%
cell loss (table 2). There was a main effect for ECD
Figure 1 Anterior segment optical coherence tomography performed 1 month after Descemet stripping automated endothelial keratoplasty
(femtosecond and microkeratome assisted) showing a posterior lamellar graft with a central thickness of 60 mm, temporal thickness of 88 mm
and nasal thickness of 81 mm.
Table 1 Central and peripheral DSAEK graft thickness measured
with anterior segment OCT at 1, 3 and 6 months postoperatively
1 month (n=25) 3 months (n=25) 6 months (n=23)
Central DSAEK graft thickness
Mean±SD (mm) 83.1±23.6 79.6±14.5 69.3±14.2
Range (mm) 53–127 54–98 49–96
Peripheral DSAEK graft thickness
Mean±SD (mm) 107.5±26.2 104.5±32.3 105.3±29.7
Peripheral thickness was obtained as the average of values obtained at 3 mm either
side of the vertex of the cornea.
DSAEK, Descemet stripping automated endothelial keratoplasty; OCT, optical
coherence tomography.
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(F(2,42)=39.40; p<0.001; ηp
2=0.85) with statistically signiﬁcant
differences between donor ECD and ECD at 3 and 6 months
(multiple comparisons; p=0.001 and p<0.001, respectively)
while the ECD decline between 3 and 6 months was not signiﬁ-
cant (p=0.99).
In order to evaluate the inﬂuence of concomitant cataract
surgery in terms of visual acuity, graft thickness and endothelial
cell loss, we also compared patients undergoing only DSAEK with
those having concurrent cataract surgery. In terms of visual acuity
at 3 and 6 months, there were no statistically signiﬁcant differences
between the two groups (DSAEK group: 0.14±0.12 logMAR and
0.11±0.09 logMAR at 3 and 6 months vs the concurrent cataract
surgery group: 0.16±0.06 logMAR and 0.14±0.06 logMAR;
independent samples t test: p=0.71 and p=0.13 at 3 and
6 months). There were no differences in central graft thickness
(DSAEK group: 80.8±16.4 mm (mean±SD) and 70.0±17.4 mm
at 3 and 6 months vs the concurrent cataract surgery group: 76.8
±9.8 and 68.3±9.7 mm; p=0.66 and p=0.86 at 3 and 6 months).
The same was true for peripheral graft thickness (p=0.45 and
p=0.38 at 3 and 6 months, respectively) and ECD (p=0.97 and
p=0.25 at 3 and 6 months, respectively).
Grafts unfolded successfully in the anterior chamber in all
surgeries. There were no graft detachments, pupillary blocks or
primary graft failures.
DISCUSSION
The inﬂuence of endothelial graft thickness on visual acuity in
DSAEK is controversial.7–10 13 However, studies on this subject
have focused either on relatively thick grafts (160–170 mm) or
on grafts prepared by manual dissection.8–10 13 14 Assessment of
grafts of less than 130 mm shows a positive correlation between
thickness and visual acuity,6 7 suggesting that an effect may exist
under a certain thickness. Even though other factors may also
inﬂuence visual acuity, such as the extension and duration of
preoperative corneal oedema and the irregularity of the anterior
cornea surface, graft thickness seems to be an important factor.
Few techniques for creating grafts thinner than 100 mm have
been presented.15–17 Therefore, to evaluate the inﬂuence of
graft thickness on visual acuity we must have a technique that
will consistently yield thin grafts.
The technique we describe in this paper involves performing
a femtosecond laser ﬁrst to prevent the variability of a double
microkeratome cut and reduce the risk of perforation.
Avoidance of a double femtosecond cut reduces the risk of a
rough stromal bed and endothelial damage.18 19
Despite aiming for grafts of less than 100 mm, a target graft
thickness ﬁgure of 110 mm was used in the formula for safety
reasons. Thus, approximately 410 mm of corneal tissue is cut
with a 300 mm microkeratome head. Because the microkera-
tome we use usually cuts more than 300 mm,20 we found that
having 110 mm as the target would actually yield grafts thinner
than 100 mm without perforation. Final graft thickness is
obtained by programming the laser to cut at a customised depth
for each cornea, depending on the initial pachymetry, in order
to always leave the same thickness (approximately 410 mm) for
the microkeratome cut. Accordingly, there was no correlation
between initial donor thickness and graft thickness at any time
point because the ﬁrst cut essentially makes all corneas equal in
terms of thickness. This avoids using nomograms and perform-
ing pachymetry between cuts, and means only one microkera-
tome head is needed, here a 300 mm head, but other heads will
probably give a good result as well. Since the microkeratome cut
depth depends on several factors, such as intrachamber pressure,
tissue thickness and manual rotation speed, these factors are
kept as constant as possible to reduce variability. An important
aspect of this technique is that the thinner cut is performed ﬁrst,
leaving a thick cornea for the microkeratome. Because the anter-
ior stroma is more compact, this approach avoids irregular cuts
and buttonholes during the microkeratome cut.21 A further
advantage is that equipment already available in many cornea
centres can be used. One limitation of this technique is that
donor corneas of less than 500 mm cannot be cut because the
Intralase has a minimum ablation depth of 90 mm.
This new approach shows endothelial cell loss comparable
with that reported for standard DSAEK and visual results
similar to published DMEK results.8 22–28 In general, endothe-
lial cell loss can result from overmanipulation. However, we
used the same DSAEK technique as we did previously with
thick grafts; there were no complications, and the grafts
unfolded successfully in the anterior chamber in all procedures.
Moreover, it is also known that organ cultured corneas systemat-
ically carry non-viable endothelial cells that are implicated in
Table 2 Preoperative and postoperative best corrected visual acuity (CDVA in Snellen and logMAR) and spherical equivalent (D)
Preoperative 3 months 6 months
Snellen CDVA (logMAR mean±SD) 20/160 (0.91±0.58)* 20/30 (0.15±0.09)† 20/25 (0.11±0.07)
Spherical equivalent D (mean±SD) −1.31±2.5 −1.06±1.75 −0.7±0.92
ECD (cells/mm2) 2675 (donor cells)‡ 1827±241§ 1729±296
Endothelial cell density (ECD) (cells/mm2) of the donor corneas, as supplied by the eye bank and mean ECD at 3 and 6 months postoperative.
*Statistically significant results between preoperative and 3 and 6 months (p=0.017 and 0.013).
†No statistically significant differences between 3 and 6 months (p=0.56).
‡Statistically significant differences between donor ECD and ECD at 3 (p=0.001) and 6 months (p<0.001).
§No statistically significant differences between 3 and 6 months (p=0.99).
CDVA, corrected distance visual acuity.
Figure 2 Improvement in best corrected visual acuity (BCVA)
(logMAR) and reduction in mean central graft thickness (μm) is
observed during a 6-month follow-up.
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cell death and go undetected when trypan blue staining is
used.29 There were no differences in terms of visual acuity, graft
thickness and endothelial cell loss between patients undergoing
DSAEK alone and those having concurrent cataract surgery.
Concerning visual acuity, patients without concurrent cataract
surgery were already pseudophakic, which could explain why
no differences were found. Concerning graft thickness and
endothelial cell loss, because cataract surgery is performed
before Descemet stripping and graft insertion it is not likely to
inﬂuence these parameters.
In conclusion, grafts of less than 100 mm could be safely and
consistently obtained. Although the initial results are very prom-
ising, further studies with larger patient cohorts and longer
follow-up times are necessary. Studies should also clarify the
ideal graft thickness for DSAEK, in terms of both visual recov-
ery and endothelial cell loss.
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